Levonic-Opto

Levofloxacin, the active ingredient in Levonic-Opto, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It is employed to treat bacterial eye infections such as conjunctivitis and keratitis in adult and pediatric patients.

GNH USA supplies Levonic-Opto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin ophthalmic solution is indicated for bacterial infections of the eye and related postoperative prophylaxis. - Bacterial conjunctivitis: reduces bacterial load and speeds symptom resolution. - Bacterial keratitis: eradicates causative organisms and promotes corneal healing. - Corneal ulcer: prevents progression of infection and supports tissue repair. - Post‑surgical prophylaxis: lowers risk of infection after ocular surgery.

Levofloxacin ophthalmic solution may cause local and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation upon instillation. - Redness of the conjunctiva. - Temporary blurred vision. - Tearing or increased lacrimation. - Mild eye irritation.

Serious or Rare Side Effects: - Corneal ulceration or perforation. - Severe allergic reaction (e.g., angioedema, anaphylaxis). - Tendon rupture (systemic exposure). - Peripheral neuropathy. - Phototoxic skin reactions.

Levofloxacin ophthalmic solution should be used with caution and under professional supervision. - Allergy assessment: avoid if known hypersensitivity to fluoroquinolones. - Pregnancy: safety not established; use only if benefit outweighs risk. - Breastfeeding: limited data; consider potential infant exposure. - Contact lens wearers: remove lenses before administration and wait before reinserting. - Systemic absorption: monitor for rare systemic fluoroquinolone effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levofloxacin ophthalmic solution can interact with other medications, affecting safety or efficacy.

Major Interactions (Avoid): - Systemic fluoroquinolones: additive risk of tendon rupture and QT prolongation. - Anticholinergic eye drops: may reduce ocular absorption.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: increased risk of corneal irritation. - Corticosteroid eye preparations: may mask signs of infection. - Drugs that prolong QT interval: monitor cardiac rhythm if systemic exposure is possible.